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1. Introduction  
The Tobacco Products Directive
1
 ('the Directive' or ‘TPD’), applicable since May 2016, aims at 
facilitating the smooth functioning of the internal market, protecting people’s health, particularly 
the youth, and meeting the obligations of the World Health Organisation (WHO) Framework 
Convention on Tobacco Control (FCTC). Under Article 28(1) of the TPD, the Commission must 
submit a report on the Directive’s application
2
 by 20 May 2021. The report must discuss, 
specifically, the elements of the Directive that should be reviewed given scientific and technical 
developments, including internationally agreed rules and standards on tobacco and related 
products. 
The TPD has aimed to reduce tobacco consumption by 2% within five years of its transposition
3
. 
Based on the latest Eurobarometer
4
, smoking prevalence among those aged 15+ fell from 26% in 
2014 to 23% in 2020 – a drop
5
 of 3 percentage points since the TPD came into force, equivalent to 
12.5%. Youth smoking rates fell to 20% in 2020 from 25% in 2014, after peaking at 29% in 2017. 
However, the uptake of emerging products, especially e-cigarettes, is growing among young 
people
6
. This is worrying given the aim to protect the youth.  
Significant developments since the Directive came into force have given new urgency and impetus 
to tobacco control work. At international level, the Sustainable Development Agenda called on all 
countries to implement the FCTC more robustly. At EU level, the  2021 Europe’s Beating Cancer 
Plan places tobacco control at the spotlight of disease prevention efforts to help achieve a tobacco-
free Europe by 2040. The intermediate objective is to reach the WHO target of a 30% relative 
reduction in tobacco use by 2025 as compared to 2010
7
, translating into an EU smoking 
prevalence rate of around 20% by 2025 compared to 29% in 2010. To meet these ambitions, 
tobacco control efforts must be stepped up, including strengthening rules on tobacco products.  
2. Transposition, application and enforcement (Articles 2, 23 and 24)  
2.1. Compliance assessment (transposition and conformity checks)  





 and 2 Commission reports
10
 allowing for all the Directive’s provisions to be fully 
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and timely implemented. Member States were required to bring into force the laws, regulations 
and administrative provisions to transpose the TPD by 20 May 2016, and provide the Commission 
with the text of these provisions. A large number of Member States did not transpose the Directive 
in time and in July 2016, the Commission launched 18 infringement proceedings based on late or 
incomplete notification of national transposition measures. The Member States in question 
subsequently communicated such measures and the Commission closed all these cases by 2020. 
The Commission has been systematically assessing the conformity of national provisions with the 
Directive on the basis of six priority areas
11
. This conformity check is ongoing and has been 
completed for a first group of Member States. While scrutinising these provisions, the 
Commission found deficiencies and variations in the Directive’s transposition, most importantly 
related to certain definitions
12
, to provisions in the areas of ingredients and emissions, labelling 
and packaging, novel tobacco products, e-cigarettes and the traceability and security features 
systems. The Commission is holding structured bilateral dialogues with Member States to ensure 
conformity. As several of the Directive’s provisions are complex, there is still a risk that their 
interpretation and practical implementation may lead to different outcomes across Member States.  
2.2. Application and enforcement 
In 2014, the Commission established a group of experts on tobacco policy
13
 (the ‘Expert Group’), 
composed of Member State representatives to provide expertise and help Member States and the 
Commission cooperate on tobacco control policies and legislation. Furthermore, in line with 
Article 26 of the Directive, the Commission published a list of competent authorities
14
 designated 
by Member States to implement and enforce the Directive. Discussions in the Expert Group 
meetings and bilateral contacts in the context of conformity checks revealed that enforcement 
activities are rather limited in several Member States. The levels of enforcement, control and 
sanctions vary considerably across the EU. Not all Member States had the capacity or resources to 
ensure that only compliant products were placed on the market
15
. Moreover, despite Member 
States` efforts to agree on a common approach, several of the Directive’s provisions are not 
applied in a harmonised manner.  
The Directive has a specific provision on cooperation among Member States’ enforcement 
authorities. Feedback from discussions in the Expert Group meetings shows that Member States 
are willing to have a forum, which so far met once in June 2019, to exchange information and 
share best practices on enforcing the Directive.   
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2.3. Court cases16 
Since entering into force the Directive has endured several legal challenges. In 2016, the European 
Court of Justice upheld its validity and that of several of its provisions, and in 2019, dismissed an 
action to annul delegated and implementing acts on the traceability systems and security features 
for tobacco products. The Court also rendered judgements on the prohibition of tobacco for oral 
use, the classification of chewing tobacco products and prohibition in stages of flavoured products 
and the relevant labelling provisions. Several court cases addressed unfounded claims about the 
library of pictorial health warnings. The latter have also endured national court procedures where 
such claims were dismissed. About half of Member States reported national court cases related to 
the Directive’s enforcement. 
2.4. Notifications (including under Articles 24(2) and 24(3)) 
Several Member States exercised their right under Articles 24(2) and 24(3) to maintain or 
introduce further requirements than those laid down in the Directive. By the time of drafting this 
report, eight Member States notified to the Commission national requirements on standardising 
the packaging of tobacco and related products justified on public health grounds, together with the 
grounds for introducing them. The Commission also approved national measures banning a certain 
category of tobacco products notified by three Member States under Article 24(3)
17
. In addition, 
Member States continuously notify their national laws on tobacco control to the Commission, 
including those covering areas not harmonised by the Directive (e.g. bans on flavours in e-
cigarettes, rules on nicotine-free e-cigarettes, smoke-free environments, age limits) under the 
procedure established by Directive 2015/1535/EU
18
. Following the assessment, the Commission, 
when needed, acts to ensure the Directive is correctly implemented.  
2.5. Conclusions on transposition, application and enforcement 
The European Court of Justice has upheld the Directive’s validity and that of several of its key 
provisions and addressed questions about its interpretation. The experience gained in the 
compliance assessments of the national transposition measures suggests that there is some 
variation in the transposition of the Directive’s provisions into national law. Therefore, various 
options to streamline the legislative framework should be explored. A number of definitions may 
also need to be adapted. The level of enforcement varies considerably among Member States and 
the lack of a legal basis for EU-level audits limits the Commission’s ability to get an accurate 
overview of Member States’ implementation and enforcement activities.   
3. Ingredients and emissions (Articles 3-7)  
3.1. Emissions and measurement methods (Articles 3 and 4) 
The TPD sets maximum emission levels for tar, nicotine and carbon monoxide (TNCO), to be 
measured using ISO methods. Articles 4(3) and 4(5) empower the Commission to adapt the 
methods for measuring TNCO based on scientific and technical developments or internationally 
agreed standards, and integrate standards agreed by the FCTC or by the WHO into EU law. 




 See notifications under Article 24(3) of the Directive: https://ec.europa.eu/health/tobacco/products/notifications_en  
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Discussions on TNCO measurement methods were held in international fora, including the 
FCTC
19
, concerning mostly ISO methods and the Canadian Intense Smoking Regime
20
. It was 
agreed that no current smoking regime adequately represents human smoking behaviour
21
. Since 
then there have been no new scientific and technical developments that warrant a change to the 
method prescribed.  
In the EU, laboratories approved by Member States' competent authorities should monitor and 
verify TNCO measurements. The Commission published the list of such laboratories
22
. Except for 
one, no Member State has set any emission limits apart from TNCO for cigarettes, nor mandated 
any additional measurement methods.  
3.2. Reporting of ingredients and emissions (Article 5)  
The Commission developed the EU Common Entry Gate (EU-CEG) system to facilitate the 
reporting in electronic format of the information on ingredients and emissions required under 
Article 5. Overall, the EU-CEG system has operated smoothly and fulfilled its core objectives as a 
data repository
23
, while reducing the administrative burden for manufacturers, importers and 
national regulators. The Commission set up a Joint Action on Tobacco Control
24
 to further help 
Member States analyse and publish EU-CEG data on ingredients and emissions. The Joint Action 
helped Member States to make information publicly available online, as required under Article 
5(4). The publication process was difficult, partly due to some submitters misusing the 
confidentiality tag. 
The EU-CEG system hosts a lot of valuable data and information. However, despite efforts via the 
Joint Action, Member States have so far seldom used it for enforcement and regulatory purposes. 
Moreover, the data are not complete for certain mandatory variables, e.g. sales data. EU-wide 
analysis, to look at the single market, is hindered by national ‘ownership’ of data, with some 
Member States unwilling to share their data. The EU-CEG is costly and resource intensive for the 
Commission. To date, only about half of the Member States have charged fees for handling 
information on ingredients under Article 5(8). Reference laboratories, established in several other 
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 So far, over 5 500 economic operators applied for a submitter ID. Almost 2400 submitted their products (over 42 
000 tobacco and 300 000 e-cigarettes are active in EU-CEG at the moment).  
24
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policy areas, do not exist. The Joint Action improved the situation somewhat. Overall, however, 
most resources were still used for setting up and maintaining the data repository, in detriment of 
data analysis, research and policy development, which would allow the data to be used for 
meaningful action.   
The practical experience of establishing the EU-CEG showed that creating an EU database with 
information on ingredients and emissions from tobacco products would be technically possible. 
However, given the constraints on Commission and Member States’ resources
15 
as well as the 
national ownership of data, such a database might be limited in added value without a robust and 
fee-funded European system for assessing ingredients (as per Article 28(2)(d)). Therefore, the 





3.3. Priority list of additives and enhanced reporting obligations (Article 6) 
Under Article 6(1), the Commission adopted a Decision
26
, establishing a priority list of 15 
additives, selected on the basis of the SCENIHR scientific opinion
27
. This opinion considered 
available data which suggested that an additive may i) contribute to toxic, addictive or 
carcinogenic, mutagenic or reprotoxic properties of cigarettes and roll-your-own (RYO) tobacco, 
ii) may result in a characterising flavour, or iii) may facilitate inhalation or nicotine uptake.  
Some 12 major manufacturers worked jointly within an ad hoc industry consortium and submitted 
the reports for 14 priority additives within the legal deadline. For one priority additive – diacetyl – 
the original deadline was not met. Several Member States have taken additional action to ensure 
compliance. The Joint Action peer-reviewed the reports and noted several deficiencies
28
 which – 
as specifically requested by Member States – the Commission communicated to industry. While 
industry provided certain clarifications, Member States could not confirm that any chemical 
substance studied would not contribute to the harmful effect of tobacco use. Overall, the 
experience with applying Article 6 shows that the reports submitted provided little actionable 
information while requiring the Commission and Member States to invest considerable resources 
into reviewing them.  
Based on current experience, resource needs must be carefully considered when judging the 
feasibility of establishing, at EU level, a positive list of ingredients and a database. A more 
structured and permanent mechanism for assessing ingredients would be needed, taking into 
account their chemical and physical properties when both burnt and unburnt, including effects of 
the emissions when not burnt.  
3.4. Regulation of ingredients (Article 7) 
From May 2016, the TPD prohibits cigarettes and RYO tobacco with characterising flavours from 
being placed on the market. A four-year phase-out period had been agreed by the co-legislators for 
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products with characterising flavours with a significant market share (i.e. menthol). So, from May 
2020, there are no more exemptions. While there is no reported issue with compliance for 
characterising candy or fruit flavours, recent developments suggest less compliance with the 
menthol ban. The exemption for tobacco products other than cigarettes and RYO tobacco must be 
withdrawn if a ‘substantial change of circumstances’ can be established (see section 10). 
The Commission invested substantial effort and resources into establishing and running the 
advisory mechanism to help decide whether or not a tobacco product has a characterising flavour. 
This mechanism comprises the Independent Advisory Panel (IAP) on characterising flavours in 
tobacco products, which has the format of a Commission expert group, and the Technical Group 
of Sensory and Chemical Assessors, established via public procurement. In practice, implementing 
the ban on characterising flavours has proven resource-intensive and cumbersome, while the 
Member States and the Commission have limited resources. Several Member States have also 
banned certain additives in line with Article 7(6).  
3.5. Conclusions on ingredients and emissions 
Overall, the Member States and the Commission have put a lot of effort and resources into 
implementing Articles 3-7. However, the effective added value for human health and the 
efficiency of certain provisions is negligible. While the set-ups of the main system – the EU-CEG 
and the Independent Advisory Panel – are fully operational and functional, they are very labour-
intensive and neither the Commission nor Member States currently have sufficient resources to 
use them optimally. It is therefore suggested to study, how the harmonised EU level assessment of 
ingredients and products, including the EU-CEG information, can be improved and organised in a 
more robust and effective way.  
The work on priority additives provided little actionable information so far and its usefulness 
should be reviewed. The discussion around the machine measurement methods is still 
inconclusive.  
4. Labelling and packaging (Articles 8-14)  
4.1. General warnings, information messages and combined health warnings 
(Articles 8-12) 
The Directive introduces requirements for mandatory health warnings on tobacco and related 
products, including combined health warnings for tobacco products for smoking. The Commission 
adopted two implementing acts to specify where health warnings are to be placed on pouches of 
RYO tobacco
29
, and to specify the layout, design and shape of the combined health warnings
30
. 
The Commission also developed the library of picture warnings included in Annex II of the 
Directive
31
. Harmonising labelling and packaging rules were a key success of the TPD as it 
standardised packaging across the internal market. 
Compulsory combined health warnings covering 65% of the front and back surfaces of tobacco 
packs was an important improvement of labelling measures compared to the Directive 
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. These have been effective in increasing public awareness of the harmful effects of 
tobacco products, and they could be associated with a decrease in tobacco consumption
15
. 
Complaints were received from people claiming that they or their relatives appeared in pictures 
without their consent, including hundreds of letters and several court proceedings
33
. All of these 
claims were proven to be manifestly unfounded.  
Based on the information of the Commission, Member States appear to be largely applying 
labelling rules properly, with some exceptions as outlined below.  
While harmonised labelling provisions are key example of those TPD provisions that have helped 
improve the internal market’s functioning, a number of implementation challenges were 
reported
15
. Article 9(3) provisions on the minimum dimensions of lateral health warnings – which 
translate into a ban
34
 on slim cuboid packages less than 20 mm deep – were applied variably. 
There were also questions about the calculation of the surface area for health warnings on bevelled 
or rounded packs in line with Recital 28
35
, and varying degrees of compliance EU-wide. A few 
Member States made suggestions
15
 about incorporating provisions on bevelled edges into the 
Directive’s text, or banning packs with bevelled edges altogether.  
Article 11(1) allows Member States to exempt tobacco products for smoking other than cigarettes, 
RYO tobacco and waterpipe tobacco from carrying the information message and the combined 
health warnings. They still need a label with a text warning and the general warning, and a 
reference to cessation services. To date, about half of Member States reported exemptions allowed 
through Article 11. Some criticised the exemption, pointing to industry pressure, and warned that 
consumers may view these exempted products as more attractive or less harmful
15
. Article 11(6) 
empowers the Commission to withdraw the possibility of exemptions if there is a substantial 
change of circumstances. However, the set of criteria for the ‘substantial change of circumstances’ 
clause laid down in Article 2(28) (see chapter 10) makes it very difficult to apply.  
The Article 12 provisions on smokeless tobacco labelling were in most cases applied properly 
without any major issues reported.  
4.2. Product presentation, pack harmonisation and plain packaging (Articles 13, 
14, 24(2)) 
Article 13 on product presentation provides for a broad ban on promotional elements. Many 
Member States had difficulties in interpreting and implementing Article 13 provisions, especially 
in clarifying the Article’s scope, and in determining non-compliance. Product presentation is an 
area rife with non-compliance and attempts to circumvent the law, with legal challenges occurring 
in several Member States
15
.  
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 on packaging are generally well understood and implemented.  
Eight Member States exercised their right under Article 24(2) to go beyond the TPD’s labelling 
provisions and introduced standardised packaging for tobacco products, i.e. plain packaging. 
These Member States notified these measures to the Commission, along with the grounds for 
introducing them, justified by public health considerations and they also proved that these 
measures are proportionate and do not constitute means of arbitrary discrimination. Based on 
evidence
15
 from Member States, plain packaging along with pictorial warnings appear to increase 
awareness of tobacco related-diseases and associated illnesses, and the motivation to quit, and 
help to reduce smoking, including among young people. About half of Europeans are in favour of 
introducing ‘plain packaging’ for cigarettes
4
. These measures align with international 
developments, as plain packaging is the golden standard promoted by the WHO and the FCTC, 
and has been upheld as consistent with international trade law in a landmark WTO ruling
37
. 
Stricter regulation through plain packaging also helps with implementing product presentation 
provisions, namely a full ban on promotional elements. However, the introduction of plain 
packaging requirements only in some Member States can be an obstacle to free movement of 
goods. Moreover, formats of standardised packaging may differ between Member States, 
additionally distorting the internal market’s smooth functioning.  
4.3. Conclusions on labelling and packaging 
Overall, labelling and packaging rules are applied properly across the EU. Those rules have led to 
– especially via enlarged combined health warnings – better awareness and understanding of the 
various product categories and health effects of tobacco use. Based on this success, the extent to 
which stronger labelling rules would work for all tobacco product categories should be examined. 
Some provisions on the packaging/appearance of unit packets should be further examined, 
particularly the size of warnings, the ban on promotional elements and on ‘slim packages’, and the 
bevelled edges.  
Several Member States went beyond the TPD provisions and have successfully rolled out 
plain/standardised packaging. Therefore, plain packaging with larger health warnings should be 
also further examined. 
5. Traceability and security features (Articles 15 and 16)  
Articles 15 and 16 provide for EU-wide systems of traceability and security features for tobacco 
products to address illicit trade. In December 2017, the Commission adopted legislation as regards 
technical details to establish the systems of traceability and security features for tobacco 
products
38
. The systems began operating in May 2019 within the deadline stipulated by the 
Directive. Since then, every newly manufactured or imported unit packet of cigarettes and RYO 
tobacco products have been marked with a unique identifier and bear a security feature. Since the 
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stock exhaustion period ended in May 2020, non-traceable cigarettes and RYO tobacco products 
can no longer be traded. The systems will be expanded to cover all other tobacco products in May 
2024. 
5.1. Traceability 
By the end of 2020, the EU traceability system collected information on 795 000 companies and 
1 520 000 facilities handling tobacco products. The manufacturers and importers of cigarettes and 
RYO tobacco products received and applied 45 billion unique identifiers, generated by the ID 
issuers appointed by Member States. The system’s central components, the secondary repository 
and the router, operated by Dentsu Aegis Network under a concession contract with the 
Commission, handled billions of messages on logistics and transactions in the supply chain.
39
 
The EU traceability system was implemented with due regard to the WHO FCTC Protocol on 
Illicit Trade (ITP), in particular Article 8 thereof. The system’s design fully complies with the ITP 
provisions. None of the ITP Party’s formal obligations was delegated to the tobacco industry. 




Altogether, Member States appointed 22 different entities to act as ID issuers, 17 being state-
controlled entities, including national printing houses. There are also five private IT companies 
contracted by eight Member States. Both public and private entities have been fully integrated into 
the system and their different statuses have not affected its day-to-day operations. 
By the end of 2020, the Commission had approved 46 data storage contracts for providing primary 
repositories, which were concluded by the manufacturers and the importers of tobacco products 
with 10 different providers, although four of them are in the same corporate group. The contracts 
were, among other things, verified against the key contractual elements laid down in Regulation 
(EU) 2018/573, while the providers were screened in view of the independence requirements 
under Article 35 of Regulation (EU) 2018/574. The Commission also rejected one data storage 
contract along with one proposed provider. 
For the first annual cycle of primary-repository audits, the Commission approved 15 auditors 
proposed and paid by the tobacco manufacturers. The Commission collected declarations 
concerning anti-tampering devices from the providers who installed them on the production lines 
for which 10 manufacturers and importers of tobacco products were responsible. 
All Member States’ competent authorities and DG OLAF are connected to the interfaces provided 
by the secondary repository operator, and many of them started using the traceability data to help 
with enforcement. Those activities are further facilitated with a mobile inspection application 
supplied by Dentsu Aegis Network under a separate agreement with the Commission. Several 
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Member States use or intend to use the EU system
41
 to supply data to their own enforcement 
systems.  
Although the system works and represents a major step in the fight against illicit trade, Member 
States and the Commission had considerable problems with the quality of traceability data, e.g. in 
relation to VAT numbers, information on production machines or on last movements of products 
to retail outlets. While data quality has gradually improved, it remains critical for enforcement and 
for fully attaining the system’s objectives. 
5.2. Security features 
To comply with the security feature provisions, 22 Member States decided to rely on and, if 
necessary, adapt their pre-existing tax stamp and fiscal marking programmes. The remaining five 
Member States introduced new authentication labels. In this sense, the system of security features 
allowed a largely similar security standard to be established EU-wide. 
5.3. Conclusions on traceability and security features 
Despite the issues affecting data quality, the traceability system is fully functional and well 
established. The Commission will examine whether the system’s long-term performance can be 
improved with stronger audits in terms of their scope, operational impact and safeguards 
guaranteeing their impartiality and public trust. 
6. Cross-border distance sales (Article 18)  
More than half of the Member States banned cross-border distance sales of tobacco and/or related 
products to consumers in their countries. The vast majority of the Member States allowing cross-




Monitoring and enforcing cross-border distance sales bans or restrictions have proven challenging. 
Member States found unregistered retailers operating in their countries or retailers selling non-
compliant or banned products. Also, cross-border distance sales occurred in Member States where 
they were banned. Only a few Member States claimed to monitor unregistered retailers’ activity 
and admitted difficulties in closing their websites especially when the servers were located outside 
the EU. In addition, age verification systems do not seem to be effective, with Member States 
calling for improved age verification systems
42
. 
Member States had difficulties controlling cross-border distance sales, with many signalling the 
need for strong enforcement cooperation. Some Member States acted against non-compliant 
retailers. Moreover, Member States highlighted problems with the TPD definition of ‘cross-border 
distance sales’. 
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6.1. Conclusions on cross-border distance sales 
Generally, there is insufficient monitoring and enforcement of cross-border distance sales 
restrictions or bans under the TPD. Age verification systems seem to be ineffective, vary between 
Member States and are poorly enforced. Not all Member States have published lists of registered 
retailers as required. There are difficulties in dealing with retailers/websites located outside the 
EU. The clarity of certain provisions, especially the definition of ‘cross-border distance sales’ may 
be improved. Given the persistent disparities between Member States and concerns over cross-
border distance sales of non-compliant products, there is scope for developing further the current 
regime, or as an alternative consider banning cross-border distance sales of tobacco and related 
products, as many Member States have already done. 
7. Novel tobacco products (Article 19) and other emerging products  
The TPD provisions for ‘novel tobacco products’ were designed to provide a wide regulatory net 
for new tobacco product categories rapidly entering the EU market. However, the date-based 
definition
43
 means that provisions are not specific to the unique characteristics of certain new 
products. Moreover, the TPD does not fully capture certain new products not containing tobacco, 
such as oral nicotine pouches. These are non-pharmaceutical in nature and are sold as consumer 
products, resembling tobacco for oral use, which the TPD bans under Article 17
44
. 
Also challenging is the use of flavours, which particularly appeal to young people. Novel tobacco 
products are exempted from the ban on characterising flavours (Article 7 (12)). The TPD gives 
scope for withdrawing this exemption, but there is a significant regulatory barrier – the 
Commission has to demonstrate a ‘substantial change of circumstances’ (see chapter 10).  
Heated tobacco products (HTPs), the prominent type of novel tobacco products, have increased 
their presence in the EU market
45
, with EUR 2.92 billion in sales in 2019
46
 (2% of the tobacco 
market). In 2020, 7% of Europeans aged 15-24 had (at least) tried HTPs and 2% were current 
users. 
Views differ over the extent to which novel tobacco products, especially HTPs, negatively affect 
the individual user’s health. While the industry often presents HTPs as reduced-risk products 
compared to conventional tobacco products, claiming they help smokers quit, worrying trends of 
popularity exist among youths
47
. Evidence also shows that many users
48
 become ‘dual users’
49
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despite intending to reduce consumption of another tobacco product. As other tobacco products, 
HTPs contain nicotine, an addictive substance, and evidence shows that HTPs emit chemical 
substances, including several toxicants
50
.  
The application of TPD provisions to novel tobacco products depends on whether these products 
are defined as a smokeless tobacco product or a tobacco product for smoking (Article 19(4)). A 
smokeless tobacco product is defined as lacking a combustion process. This is a challenge for 
regulators as the principle of combustion is ambiguous, leading to Member States classifying 
certain products in a divergent manner, as also addressed at international (WCO) level
51
. 
Moreover, without flexibility to define new product categories, it is challenging to apply rules 
developed for existing categories to novel tobacco products, as they do not necessarily respond to 
the distinct properties of the new products.  
These novel tobacco products also pose challenges for applying tobacco control measures overall, 
including on advertising and smoke-free environments. The device specifically designed for 
consuming such products is widely promoted in some Member States, thus circumventing the 
tobacco advertising bans. Classifying a product as smokeless may also lead to smoke-free 
environment laws, historically focused on tobacco products for smoking, being circumvented. To 
clarify the issues above and address the regulatory challenges posed by these products, the EU 
initiated and supported a mandate at the WHO FCTC COP8
52
.  
7.1. Conclusions on novel tobacco and emerging products 
The EU regulatory framework does not currently address all novel tobacco and emerging 
products, nor provide flexibility to address rapid product developments. HTPs should be 
monitored closely as they pose specific regulatory challenges, including health warnings, use of 
flavours and interaction with devices. There are also legal loopholes with respect to emerging 
nicotine or similar products (excluding those authorised for medical purposes and/or for smoking 
cessation under medical authorisation). 
8. Electronic cigarettes and refill containers (Article 20)  
E-cigarettes, containing nicotine but no tobacco, are a specific diverse product category, 
accounting for up to 7% of the national EU markets, in terms of value, for tobacco and related 
products
53
. The EU-CEG contains over 300 000 active e-cigarettes, compared to over 42 000 
active tobacco products
54
. In recent years, big tobacco companies have increased investments in e-
cigarettes.  
The EU was the first regional jurisdiction to regulate them, including advertising. To capture a 
wide net of diverse products, the TPD broadly defines this category to encompass both the device, 
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including its parts, and refill containers with nicotine containing e-liquid. This has provided legal 
clarity, particularly when compared to provisions on novel tobacco products, where the device is 
not specifically captured. The Commission adopted two implementing acts and a report on risks 
associated with refillable e-cigarettes
55
. 
Overall, Member States had a fairly good experience with implementing certain provisions on e-
cigarettes, with scope for improvement in other specific areas. While manufacturers and importers 
submit notifications to the competent authorities, in line with Article 20(2), more could be done to 
provide higher quality information, particularly on toxicological data and consistent nicotine doses 
upon consumption, e.g. by standardising assessment methods. Certain provisions have proven 
challenging to implement in practice, e.g. health warnings under Article 20(4)(b)(iii) not only 
apply to refill containers or pre-filled devices but also to the e-cigarette device itself. Further 
specification and more differentiated warnings would help, in particular when a product is 
marketed without a nicotine-containing liquid. Also, questions over interpretation were raised over 
i) labelling requirements for unit packets and outside packaging, ii) the information allowed under 
the exemption from the bans of promotional elements (e.g. nicotine content and information on 
flavourings), and iii) the limits for the tank size.  
Applying Article 20(5) – banning commercial communications and sponsorship activities to 
promote e-cigarettes - continues to be challenging, especially in information society services and 
on social media where young people are particularly exposed/targeted.  
Regarding reporting market surveillance activities, Member States have a legal obligation to 
report dangerous e-cigarettes, chargers supplied with them and refill containers in the Safety 
Gate/RAPEX, as well as, measures taken against them. The Information and Communication 
System for Market Surveillance (ICSMS) is also available to authorities to exchange information 
on non-compliant products. However, the use of these tools by Member States is uneven.  
Safety concerns related to e-cigarettes spiralled worldwide in 2019 with ‘EVALI’ (E-cigarette or 
Vaping Associated Lung Injury) cases rising sharply in the USA
56
. These cases have since been 
linked to cannabis extract and/or vitamin E acetate containing e-liquids. EU countries have not 
observed this trend, possibly due in part to the specificities of e-cigarette regulation under the 
TPD, notably additive restrictions, e.g. a ban of vitamins in nicotine-containing liquids. These 
events show that the toxicological effects of the heated and inhaled forms of ingredients of both 
nicotine-containing and (thus far unregulated) nicotine-free e-cigarettes should be highlighted. 
The TPD also sets a maximum nicotine concentration of 20 mg/ml and overall this has been 
implemented, although industry use of technical features can increase nicotine uptake per puff.  
The industry presents e-cigarettes as reduced-risk products and claims that they help smokers to 
quit. However, worrying trends of popularity
57
 exist among youths. There is strong evidence that 
flavours in e-liquids are attractive to youths and adults. Significantly, young people use non-
                                                 
55
 Commission Implementing Decision (EU) 2015/2183, Commission Implementing Decision (EU) 2016/586, 
COM/2016/0269 final. 
56
 CDC. Outbreak of Lung Injury Associated with E-cigarette Use, or Vaping. Feb 2020 
https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html  
57
 LSE 2020. The two main reasons for using e-cigarettes were ‘enjoyment’ and ‘trying to quit or reduce consumption 
of a tobacco product’. Yet quitting or reducing consumption was more pronounced for those aged over 26 (54%), 








. These flavours strongly influence 
young people by decreasing harm perception and increasing the will to try
59
. Member States are 
increasingly banning flavours for e-cigarettes. 
Views on the actual health effects of e-cigarettes are divided, ranging from harmful to harm-
reducing for the individual, compared to conventional tobacco products for smoking. As scientific 
consensus has yet to be reached, the precautionary principle prevails and the TPD takes a careful 
approach in regulating these products
60
. The WHO further concluded that no firm evidence exists 
on the safety of e-cigarettes, but there is increasing evidence of harm
61
. Also, there is concern over 
increased indoor use
62
 and potential related harm. 
To better understand the health effects and the public health dimension of e-cigarettes, the 
Commission has tasked the Scientific Committee on Health and Environmental Risks (SCHEER) 
to study the health effects of e-cigarette use, and their role in encouraging people to start or quit 
smoking. For users of electronic cigarettes, they found moderate weight of evidence for risks of 
local irritative damage to the respiratory tract and moderate, but a growing level of evidence from 
human data suggesting that electronic cigarettes have harmful health effects, especially but not 
limited to the cardiovascular system. More so, they found weak to moderate weight of evidence 
for risks of carcinogenicity of the respiratory tract due to long-term, cumulative exposure to 
nitrosamines and due to exposure to acetaldehyde and formaldehyde and concluded that weight of 
evidence for risk of poisoning and injuries due to burns and explosion is strong. They also found 
weak to moderate weight of evidence for several risks related to second-hand exposure. Overall, 
there is moderate evidence that electronic cigarettes are a gateway to smoking for young people 
and strong evidence that flavours have a relevant contribution for attractiveness of use of 
electronic cigarette and initiation. On the other hand, there is weak evidence for the support of 
electronic cigarettes' effectiveness in helping smokers to quit while the evidence on smoking 





8.1. Conclusions on e-cigarettes and refill containers 
E-cigarettes contain nicotine, a toxic substance. The Commission will base its risk management 
decisions on e-cigarettes on the SCHEER scientific opinion. The SCHEER opinion underlined 
their health consequences and the important role they play in smoking initiation. This opinion 
supports the careful and precautionary approach taken so far.  
However, it should be explored whether some provisions could be further developed or clarified, 
such as tank size or labelling requirements; use of flavours; use of nicotine-free liquids; and 
advertising provisions.  
Insofar as e-cigarettes are smoking cessation aids, their regulation should follow the 
pharmaceutical legislation. 
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9. Herbal products for smoking (Articles 21 and 22)  
Herbal products for smoking were newly added to the TPD. These include products based on 
plants, fruits or flowers, which can be consumed via combustion without tobacco. The TPD 
provisions complement other relevant legislative frameworks and do not regulate as such the types 
of plants, herbs or fruits contained in herbal products for smoking. Over 1 600 product 
presentations are active in EU-CEG, most of which could be linked to cannabis products for 
smoking. There are concerns over the finding that some cannabidiol (CBD) products may also 
contain tetrahydrocannabinol (THC)
63
, which is controlled under the 1971 UN Convention on 
Psychotropic Substances, of which all Member States are Parties to
64
. The 2020 Eurobarometer 
survey identified that 8% of Europeans have used products containing cannabis in the last 12 
months, most frequently by smoking it with tobacco
4
. With certain types of cannabis being 
decriminalised in a few EU countries and some other countries worldwide, interest in these 
products has increased.  
The current definition of herbal products for smoking does not capture certain new products 
entering the market, such as CBD containing cannabis extracts and oils, used particularly in e-
cigarettes (with or without nicotine). In the context of the TPD, there is lack of clarity of the 
regulation of cannabis extracts or synthetic CBD in e-liquids.  
9.1. Conclusions on herbal products for smoking 
Overall, Articles 21 and 22 of the TPD have been implemented EU-wide, with Member States 
reporting some issues around labelling requirements
15
. They also reported good compliance with 
reporting obligations on ingredients. However, a significant challenge lies in competent authorities 
ensuring that all relevant products are submitted to the EU-CEG. Nonetheless, cannabis extracts 
are currently regulated at national level. 
10. Specific consideration for other product types and categories, including 
market developments and substantial change of circumstances   
10.1. Waterpipe tobacco, slim cigarettes and other product categories  
Article 28 of the TPD tasked the Commission to also specifically look at waterpipe tobacco and 
slim cigarettes, for which it mandated a specific study
6
. On implementing provisions on slim 
cigarettes, waterpipe tobacco, and cigarillos, different experiences have been reported. Most 
Member States do not mandate pictorial warnings for cigarillos, often targeted at cigarette users 
with their lower price or features banned in cigarettes, e.g. flavour capsules. Waterpipe tobacco 
use frequently takes place in specific premises, e.g. shisha lounges, where consumers do not see 
health warning labels and pictorials. Another concern over waterpipe tobacco, as for cigarillos, is 
the use of flavours and their attractiveness to youths.  
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The EU waterpipe market is significant
65
, and some EU countries have one of the highest 
prevalence of waterpipe tobacco use among youths
66
. The slim cigarette market has been declining 
since 2000, but retail volume has increased in several Eastern European Member States
6
. More 
women smoke slim cigarettes (10%) than men (2%).   
Evidence shows that the risks associated with waterpipe tobacco are underestimated
67
. Flavour use 
is strongly linked to waterpipe tobacco, and ‘nice flavours’ was the term most frequently 
associated with these products
6
. Some people may also underestimate the risks associated with 
slim cigarette use
68
. Eurobarometer 2017 stated that 18% of respondents identified slim cigarettes 
as attractive. However, connotations of femininity are less deep-rooted
6
.  
During the reporting period, the snus ban was clearly circumvented as, outside of Sweden, many 
snus-like products were presented as chewing tobacco to gain a legal status. Legal loopholes 
related to chewing bags and emerging nicotine pouches became apparent.  
10.2. Substantial change of circumstance clause (Articles 2(28), 7(12), 11(6)) 
The TPD sets out criteria for a ‘substantial change of circumstances’
69
 and calls for the 
Commission to withdraw certain regulatory exemptions once those conditions are met (a flavour 
ban for product categories other than cigarettes and RYO tobacco, labelling exemptions). The 
Commission followed the market shares closely and no product category reached the threshold 
that would mandate the Commission to trigger this clause in the reporting period. The closest to 
the threshold are HTPs
70
. Therefore, assessing the current criteria should be considered. 
10.3. Other considerations 
The TPD enabled some tobacco control actions to be financed by fees, and some Member States 
started to use such options. Further exploration of how to fully finance tobacco control actions 
through fees is merited. The Directive does not contain provisions on the tobacco industry’s 
liability for the health effects and health costs of tobacco and related product use. However, in line 
with Article 19 of the FCTC
71
, the EU could, for the next TPD review, examine options to 
increasing tobacco manufacturers’ liability. 
11. Conclusions  
The TPD has enhanced tobacco control and its validity was upheld in courts. It strengthened rules, 
e.g. enlarged combined health warnings, the track and trace system, banning characterising 
flavours, the ingredients database, the regulation of electronic cigarettes, all of which have 
established their position as part of a comprehensive EU tobacco control policy. The TPD 
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achieved the 2% reduction target of the impact assessment with decreased smoking prevalence 
among youths. The Directive also implemented relevant WHO FCTC provisions.  
The study that gathered evidence for this report concluded that the TPD has contributed to the 
improvement of public health. The TPD provides added value and Member States could not have 
accomplished the same objectives alone. In general, the TPD was considered to be consistent 
internally, but due to market developments there is scope for improvement in certain essential 
areas. Compliance of national laws with the TPD and their harmonised application varies. Many 
Member States lack adequate enforcement resources. The new functional systems (EU-CEG, IAP, 
traceability) are relatively resource-intensive. 
Persistently high smoking rates, high numbers of youths taking up smoking, the WHO target of a 
30% relative reduction in tobacco use by 2025 as compared to 2010
7
, as well as the Europe’s 
Beating Cancer Plan’s objective to achieve a tobacco-free generation by 2040, should be duly 
taken into consideration when assessing the EU framework on tobacco and related products.  
